Your session is about to expire
← Back to Search
Weight-Loss Program for Lowering Breast Cancer Risk in Obesity
Study Summary
This trial looks at how well a weight-loss program with or without hunger-training helps lower the risk of breast cancer in obese participants.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2020 Phase 3 trial • 177 Patients • NCT01817075Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am taking medication for diabetes in pill form.I am not taking any medication that affects blood sugar, except possibly metformin.I am at high risk for breast cancer due to genetic factors or previous conditions.I am currently receiving treatment for a cancer that is not nonmelanoma skin cancer.I have been diagnosed with type 1 or type 2 diabetes.I have been treated with GLP-1 receptor agonists.I have not had a period for 12 months or have had both ovaries removed.You can take pictures with a time stamp using a digital device.Your current measured body mass index (BMI) is less than 27 kg/m^2.I have only used basal insulin, except for short-term treatments.I am at high risk for breast cancer due to my genetic history or previous conditions.I have not had a period for 12 months or have had both ovaries removed.Your blood sugar levels are too high when you haven't eaten for a while, and your HbA1c levels are above 7%.I am not willing to use a device that needs daily finger pricks for blood tests.Your body mass index (BMI) is 27 or higher.Your body mass index (BMI) is 27 or higher.
- Group 1: Group A (DPP)
- Group 2: Group B (DPP-HT)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any vacancies for individuals in this clinical trial?
"Clinicaltrials.gov attests that this clinical trial, which has been posted since December 17th 2017 and amended most recently on September 22nd 2022, is not presently enrolling patients. Nevertheless, there are 3492 active studies currently selecting participants."
Are individuals over 25 years of age eligible to participate in this research trial?
"According to the rules and regulations of this medical study, participants need to be between 30 and 70 years old."
To whom is this investigative research project open?
"This medical experiment is welcoming 51 participants aged between 30 and 70 who are living with obesity. Furthermore, these potential subjects must also satisfy the following conditions: a Gail model lifetime risk of more than 20% or 5 year risk higher than 1.66%, history of deleterious BRCA1/2 mutation or mantle radiation, history of ductal cancer in situ, record of high-risk premalignant breast lesion, BMI greater than 27 kg/m^2., 12 months without menstrual cycle or bilateral oophorectomy experience , capability to take digital time stamped photos., daily access to the internet.."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger